Cited by 359Probiotics and Fermented FoodsReproductive tract infections researchInfant Nutrition and Health

Probiotic agents and infectious diseases: a modern perspective on a traditional therapy

Alvarez-Olmos, M. I., Oberhelman, R. A.·2001·Clinical Infectious Diseases

Abstract

There is an increasing scientific and commercial interest in the use of beneficial microorganisms, or "probiotics," for the prevention and treatment of disease. The microorganisms most frequently used as probiotic agents are lactic-acid bacteria such as Lactobacillus rhamnosus GG (LGG), which has been extensively studied in recent literature. Multiple mechanisms of action have been postulated, including lactose digestion, production of antimicrobial agents, competition for space or nutrients, and immunomodulation. We have reviewed recent studies of probiotics for the treatment and control of infectious diseases. Studies of pediatric diarrhea show substantial evidence of clinical benefits from probiotic therapy in patients with viral gastroenteritis, and data on LGG treatment for Clostridium difficile diarrhea appear promising. However, data to support use of probiotics for prevention of traveler's diarrhea are more limited. New research suggests potential applications in vaccine development and prevention of sexually transmitted diseases. Further studies are needed to take full advantage of this traditional medical approach and to apply it to the infectious diseases of the new millennium.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/320518

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 104 references couldn’t be matched to a known paper.

Research works printed but not linked: 15

  1. Savage D. Mucosal microbiota. In: Pearay LO, ed. Mucosal immu- nology. San Diego: Academic Press, 1999:1-30.
  2. McGhee JR, Lamm ME, Strober W. Mucosal immune responses: an overview. In: Pearay LO, ed. Mucosal immunology. San Diego: Ac- ademic press, 1999:485-506.
  3. Cebra JJ, Jian H-Q, Sterzl J, Tlaskalova ´-Hogenova ´H. The role of mucosal microbiota in the development and maintenance of the mu- cosal immune system. In: Pearay LO, ed. Mucosal immunology. San Diego: Academic Press, 1999:267-80.
  4. Shortt C. Living it up for dinner. Chemistry Industry 1998; 8:300-3.
  5. Sanders ME. Probiotics. Food Technol 1999; 53:67-77.
  6. Hooper LV, Bry L, Falk PG, et al. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. BioEssays 1998; 20:336-43.
  7. Simon GL, Gorbach SL. Normal alimentary tract microflora. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastroenterology tract. New York: Raven Press, 1995:53-68.
  8. James SP. The immune system. In: Haubrich, Schaffner W, Berok F, Edward. Gastroenterology. 5th ed., Vol 4. Philadelphia: WB Saunders Co, 1995:3345-64.
  9. Mack DR, Michail S, We S, et al. Probiotics inhibits enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expres- sion. Am J Physiol 1999; 276:G941-G950.
  10. Michail S, Wei S, Mack DR. Escherichia coli strain E2348/69 in vitro adhesion is reduced in the presence of a Lactobacillus species [ab- stract]. Gastroenterology 1997; 112:A1042.
  11. De Simone C, Tzantzoglou S, Baldinelli L, et al. Enhancement of host resistance against Salmonella thyphimurium infection by a diet sup- plemented with yogurt. Immunopharmicol Immunotoxicol 1988; 10: 399-415.
  12. Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: fac- tors influencing development of microflora. Ann Med 1999; 31: 288-92.
  13. Hilton E, Kolakowski P, Singer C, et al. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4:41-3.
  14. Colombel JF, Cortot A, Newt C, Romond C. Yogurt with Bifidobac- terium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; 2(8549):43.
  15. Siitonen S, Vapaatalo H, Salminen S, et al. Effects of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhea. Ann Med 1990; 22:57-9.

Cited by

Sorted by citations

Authors
Alvarez-Olmos, M. I., & Oberhelman, R. A.
Affiliations
Tulane University (US)
Corresponding author
Oberhelman, R. A.
Venue
Clinical Infectious Diseases
Published
2001-06-01
Volume
32
Issue
11
Pages
1567-1576
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2145683869
Cited by
359
References
104
Citations by year
2026: 7 · 2025: 7 · 2024: 14 · 2023: 7 · 2022: 9 · 2021: 24 · 2020: 10 · 2019: 11 · 2018: 18 · 2017: 11 · 2016: 11 · 2015: 14 · 2014: 13 · 2013: 25 · 2012: 21
FWCI
3.15
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
probiotics, lactic acid bacteria, Lactobacillus rhamnosus GG, infectious diseases, childhood diarrhea, viral gastroenteritis, Clostridium difficile-associated diarrhea, traveler's diarrhea, immunomodulation, antimicrobial agents, vaccine development, sexually transmitted infections
MeSH terms
Animals, Antidiarrheals, Bifidobacterium, Biological Therapy, Communicable Diseases, Diarrhea, Gastric Mucosa, Humans, Intestinal Mucosa, Lactobacillus, Immunity, Mucosal, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review